Inflammatory pathways underlying atrial fibrillation

Trends in Molecular Medicine - Tập 17 - Trang 556-563 - 2011
Kai Friedrichs1, Anna Klinke2, Stephan Baldus2
1Department of Electrophysiology, University Heart Center Hamburg, Hamburg 20246, Germany
2Cardiovascular Research Center and Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg 20246, Germany

Tài liệu tham khảo

Kannel, 1982, Epidemiologic features of chronic atrial fibrillation: the Framingham study, N. Engl. J. Med., 306, 1018, 10.1056/NEJM198204293061703 Tsang, 2003, The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades, J. Am. Coll. Cardiol., 42, 93, 10.1016/S0735-1097(03)00500-X Wang, 2003, A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, J. Am. Med. Assoc., 290, 1049, 10.1001/jama.290.8.1049 Haïssaguerre, 1998, Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N. Engl. J. Med., 339, 659, 10.1056/NEJM199809033391003 Morady, 2003, Treatment of paroxysmal atrial fibrillation by pulmonary vein isolation, Circ. J., 67, 567, 10.1253/circj.67.567 Verma, 2010, Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial, Eur. Heart J., 31, 1344, 10.1093/eurheartj/ehq041 Schotten, 2011, Pathophysiological mechanisms of atrial fibrillation: a translational appraisal, Physiol. Rev., 91, 265, 10.1152/physrev.00031.2009 Wattigney, 2003, Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention, Circulation, 108, 711, 10.1161/01.CIR.0000083722.42033.0A Healey, 2003, Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target, Am. J. Cardiol., 91, 9G, 10.1016/S0002-9149(03)00227-3 Spodick, 1976, Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases, J. Am. Med. Assoc., 235, 39, 10.1001/jama.235.1.39 Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 Mihm, 2001, Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation, Circulation, 104, 174, 10.1161/01.CIR.104.2.174 Bruins, 1997, Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia, Circulation, 96, 3542, 10.1161/01.CIR.96.10.3542 Dernellis, 2006, Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation, Am. J. Cardiol., 97, 245, 10.1016/j.amjcard.2005.08.027 Toutouzas, 2009, Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography, Int. J. Cardiol., 134, 345, 10.1016/j.ijcard.2008.02.028 Schnabel, 2010, Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community, Circulation, 121, 200, 10.1161/CIRCULATIONAHA.109.882241 Smith, 2010, Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation, J. Am. Coll. Cardiol., 56, 1712, 10.1016/j.jacc.2010.05.049 Letsas, 2009, Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation, Europace, 11, 158, 10.1093/europace/eun309 Lin, 2010, Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation, Am. J. Cardiol., 105, 495, 10.1016/j.amjcard.2009.10.019 Dernellis, 2004, Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation, Eur. Heart J., 25, 1100, 10.1016/j.ehj.2004.04.025 Prasongsukarn, 2005, The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial, J. Thorac. Cardiovasc. Surg., 130, 93, 10.1016/j.jtcvs.2004.09.014 Leftheriotis, 2009, The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation, Int. J. Cardiol., 135, 361, 10.1016/j.ijcard.2008.04.012 Marcus, 2010, Intracardiac and extracardiac markers of inflammation during atrial fibrillation, Heart Rhythm, 7, 149, 10.1016/j.hrthm.2009.10.004 Henningsen, 2009, Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion, Scand. J. Clin. Lab. Invest., 69, 425, 10.1080/00365510802676848 Conway, 2004, Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation, Am. Heart J., 148, 462, 10.1016/j.ahj.2004.01.026 Psychari, 2005, Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation, Am. J. Cardiol., 95, 764, 10.1016/j.amjcard.2004.11.032 Carnes, 2001, Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation, Circ. Res., 89, E32, 10.1161/hh1801.097644 Ide, 2000, Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium, Circ. Res., 86, 152, 10.1161/01.RES.86.2.152 Chen, 2008, Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation, J. Mol. Cell. Cardiol., 45, 742, 10.1016/j.yjmcc.2008.07.007 Kourliouros, 2009, Current concepts in the pathogenesis of atrial fibrillation, Am. Heart J., 157, 243, 10.1016/j.ahj.2008.10.009 Dobrev, 2008, Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics, J. Cardiovasc. Pharmacol., 52, 293, 10.1097/FJC.0b013e318171924d Gramley, 2010, Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway, Int. J. Cardiol., 143, 405, 10.1016/j.ijcard.2009.03.110 Saba, 2005, Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-α, Am. J. Physiol. Heart Circ. Physiol., 289, H1456, 10.1152/ajpheart.00733.2004 Guerra, 1996, The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes, Br. J. Pharmacol., 118, 1278, 10.1111/j.1476-5381.1996.tb15534.x Donoso, 2011, Modulation of cardiac ryanodine receptor activity by ROS and RNS, Front. Biosci., 16, 553, 10.2741/3705 Terentyev, 2008, Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure, Circ. Res., 103, 1466, 10.1161/CIRCRESAHA.108.184457 Kuster, 2010, Redox-mediated reciprocal regulation of SERCA and Na+-Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes, Free Radic. Biol. Med., 48, 1182, 10.1016/j.freeradbiomed.2010.01.038 Zissimopoulos, 2006, Redox regulation of the ryanodine receptor/calcium release channel, Biochem. Soc. Trans., 34, 919, 10.1042/BST0340919 Zima, 2006, Redox regulation of cardiac calcium channels and transporters, Cardiovasc. Res., 71, 310, 10.1016/j.cardiores.2006.02.019 Chaldoupi, 2009, The role of connexin40 in atrial fibrillation, Cardiovasc. Res., 84, 15, 10.1093/cvr/cvp203 Wirka, 2011, A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation, Circ. Arrhythm. Electrophysiol., 4, 87, 10.1161/CIRCEP.110.959726 Luo, 2007, Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation, Cardiology, 107, 248, 10.1159/000095501 Patel, 2010, Update on the association of inflammation and atrial fibrillation, J. Cardiovasc. Electrophysiol., 21, 1064, 10.1111/j.1540-8167.2010.01774.x Ryu, 2007, Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias, Am. J. Physiol. Heart Circ. Physiol., 293, H1231, 10.1152/ajpheart.00607.2006 Lindsey, 2006, Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction, Circulation, 113, 2919, 10.1161/CIRCULATIONAHA.106.612960 Hagiwara, 2010, Inflammation and atrial fibrillation, Circ. J., 74, 246, 10.1253/circj.CJ-09-0986 Verheule, 2004, Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1, Circ. Res., 94, 1458, 10.1161/01.RES.0000129579.59664.9d Okumura, 2011, Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence, J. Cardiovasc. Electrophysiol., 10.1111/j.1540-8167.2011.02059.x Yue, 2011, Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation, Cardiovasc. Res., 89, 744, 10.1093/cvr/cvq329 Xu, 2004, Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation, Circulation, 109, 363, 10.1161/01.CIR.0000109495.02213.52 Barnes, 2011, Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases, Kidney Int., 79, 944, 10.1038/ki.2010.516 Hecker, 2009, NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury, Nat. Med., 15, 1077, 10.1038/nm.2005 Li, 2000, Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy, Proc. Natl. Acad. Sci. U.S.A., 97, 12746, 10.1073/pnas.97.23.12746 Rudolph, 2010, Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation, Nat. Med., 16, 470, 10.1038/nm.2124 Mott, 2004, Regulation of matrix biology by matrix metalloproteinases, Curr. Opin. Cell Biol., 16, 558, 10.1016/j.ceb.2004.07.010 Ramos-Mondragón, 2008, Role of TGF-beta on cardiac structural and electrical remodeling, Vasc. Health Risk Manag., 4, 1289, 10.2147/VHRM.S3985 Barcellos-Hoff, 1996, Redox-mediated activation of latent transforming growth factor-beta 1, Mol. Endocrinol., 10, 1077, 10.1210/me.10.9.1077 Li, 2010, Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes, Diabetes, 59, 2033, 10.2337/db09-1800 Reil, 2010, Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling, Cardiovasc. Res., 87, 485, 10.1093/cvr/cvq079 Adam, 2011, Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation, J. Mol. Cell. Cardiol., 50, 678, 10.1016/j.yjmcc.2010.12.019 Fu, 2003, Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation, J. Biol. Chem., 278, 28403, 10.1074/jbc.M304739200 Wang, 2007, Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation, J. Biol. Chem., 282, 31826, 10.1074/jbc.M704894200 Chen, 2008, Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation, Am. J. Cardiol., 102, 861, 10.1016/j.amjcard.2008.05.038 Yamashita, 2010, Recruitment of immune cells across atrial endocardium in human atrial fibrillation, Circ. J., 74, 262, 10.1253/circj.CJ-09-0644 Ramlawi, 2007, Oxidative stress and atrial fibrillation after cardiac surgery: a case–control study, Ann. Thorac. Surg., 84, 1166, 10.1016/j.athoracsur.2007.04.126 Lamm, 2006, Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery, J. Cardiothorac. Vasc. Anesth., 20, 51, 10.1053/j.jvca.2005.03.026 Finet, 2009, Information learned from animal models of atrial fibrillation, Cardiol. Clin., 27, 45, 10.1016/j.ccl.2008.09.005 Goldstein, 2008, Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model, J. Cardiovasc. Electrophysiol., 19, 74 Zhang, 2010, n-3 polyunsaturated fatty acids prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model, Int. J. Cardiol., 10.1016/j.ijcard.2010.08.024 Ishii, 2005, Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation, Circulation, 111, 2881, 10.1161/CIRCULATIONAHA.104.475194 Goette, 2008, Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression, Circulation, 117, 732, 10.1161/CIRCULATIONAHA.107.730101 McCubrey, 2006, Reactive oxygen species-induced activation of the MAP kinase signaling pathways, Antioxid. Redox Signal., 8, 1775, 10.1089/ars.2006.8.1775 Johar, 2006, Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase, FASEB J., 20, 1546, 10.1096/fj.05-4642fje Balasubramanian, 2011, The interferon-γ-induced GTPase, mGBP-2, inhibits TNF-α induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-κB and Rac, J. Biol. Chem., 286, 20054, 10.1074/jbc.M111.249326 Everett, 2007, Atrial fibrosis and the mechanisms of atrial fibrillation, Heart Rhythm, 4, S24, 10.1016/j.hrthm.2006.12.040 Sugden, 1997, Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors, Cell. Signal., 9, 337, 10.1016/S0898-6568(96)00191-X Bachschmid, 2010, Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice, Free Radic. Biol. Med., 49, 1221, 10.1016/j.freeradbiomed.2010.07.005 Li, 2011, Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts, Cardiovasc. Res., 10.1093/cvr/cvr067 Xu, 2010, Local angiotensin II aggravates cardiac remodeling in hypertension, Am. J. Physiol. Heart Circ. Physiol., 299, H1328, 10.1152/ajpheart.00538.2010 El Bekay, 2003, Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB, Blood, 102, 662, 10.1182/blood-2002-09-2785 Zhao, 2008, Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats, Mol. Cell. Biochem., 317, 43, 10.1007/s11010-008-9803-8 Xiao, 2004, Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death, Am. J. Pathol., 165, 1019, 10.1016/S0002-9440(10)63363-9 Lau, 2005, Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins, Proc. Natl. Acad. Sci. U.S.A., 102, 431, 10.1073/pnas.0405193102 Klinke, 2011, Myeloperoxidase attracts neutrophils by physical forces, Blood, 117, 1350, 10.1182/blood-2010-05-284513 Aviles, 2003, Inflammation as a risk factor for atrial fibrillation, Circulation, 108, 3006, 10.1161/01.CIR.0000103131.70301.4F